Vascular Endothelial Growth Factor Stimulates Proliferation but Not Migration or Invasiveness in Human Extravillous Trophoblast¹

^a Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, Canada N6A 5C1

Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein that promotes angiogenesis and vascular hyperpermeability and interacts with two receptors, fms-like tyrosine kinase (Flt-1) and kinase domain-containing region (KDR). In situ localization in the pregnant human uterus revealed that VEGF mRNA is expressed primarily by the maternal decidua, whereas the receptor Flt-1 is expressed primarily by chorionic vascular endothelium and trophoblast cells—in particular, the extravillous trophoblast (EVT). We examined whether the mRNA and protein of VEGF and its receptors are expressed by invasive human first-trimester EVT cells propagated in culture and whether VEGF influences EVT cell proliferation, migration, and invasiveness. Proliferation was assessed by the uptake of [³H]thymidine. Invasion and migration across transwells were assessed by the degree of cellular transgression of a Millipore membrane coated, respectively, with and without Matrigel. Results of immunocytochemical and reverse transcription-polymerase chain reaction analysis revealed that both protein and mRNA of VEGF, Flt-1, and KDR were expressed by cultured normal EVT cells as well as their premalignant derivative produced by SV-40 Tag-immortalization, and BeWo choriocarcinoma cells. Under serum-free conditions, exogenous VEGF₁₂₁ (the non-heparin-binding isoform) stimulated proliferation of all three cell lines in a concentration-dependent manner. The effects were abolished with a VEGF-neutralizing antibody. The same stimulatory effects on EVT cells were also seen with exogenous VEGF₁₆₅ (a heparin-binding isoform), only after a cleaving of the heparin-binding domain with plasmin or a blocking of heparin binding sites with excess soluble heparan sulphate proteoglycans (HSPGs), suggesting a regulatory role of HSPGs. However, VEGF₁₂₁ and VEGF₁₆₅ (with and without the HSPG pretreatment) had no effect on normal EVT cell migration or invasiveness. Thus, VEGF may provide a dual role in angiogenesis and EVT cell proliferation during normal placental development.

¹ This work was supported by a grant from The Medical Research Council of Canada.

² Correspondence: P.K. Lala, Department of Anatomy and Cell Biology, Medical Sciences Building, The University of Western Ontario, London, ON, Canada N6A 5C1. FAX: (519) 661–3936; pklala{at}julian.uwo.ca

This article has been cited by other articles:

				D. Iacob, J. Cai, M. Tsonis, A. Babwah, C. Chakraborty, R. N. Bhattacharjee, and P. K. Lala Decorin-Mediated Inhibition of Proliferation and Migration of the Human Trophoblast via Different Tyrosine Kinase Receptors Endocrinology, December 1, 2008; 149(12): 6187 - 6197. [Abstract] [Full Text] [PDF]

				C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF]

				C Bearfield, E Jauniaux, N Groome, I L Sargent, and S Muttukrishna The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro Eur. J. Endocrinol., June 1, 2005; 152(6): 909 - 916. [Abstract] [Full Text] [PDF]

				S. Tartakover Matalon, A. Ornoy, A. Fishman, L. Drucker, and M. Lishner The effect of 6-mercaptopurine on early human placental explants Hum. Reprod., May 1, 2005; 20(5): 1390 - 1397. [Abstract] [Full Text] [PDF]

				W. P. J. Leenders, B. Kusters, K. Verrijp, C. Maass, P. Wesseling, A. Heerschap, D. Ruiter, A. Ryan, and R. de Waal Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option Clin. Cancer Res., September 15, 2004; 10(18): 6222 - 6230. [Abstract] [Full Text] [PDF]

				S. Campbell, J. Rowe, C.J. Jackson, and E.D.M. Gallery Interaction of Cocultured Decidual Endothelial Cells and Cytotrophoblasts in Preeclampsia Biol Reprod, July 1, 2004; 71(1): 244 - 252. [Abstract] [Full Text] [PDF]

				J.-Y. Chung, Y. Song, Y. Wang, R. R. Magness, and J. Zheng Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2484 - 2490. [Abstract] [Full Text] [PDF]

				E.Y. Anteby, C. Greenfield, S. Natanson-Yaron, D. Goldman-Wohl, Y. Hamani, V. Khudyak, I. Ariel, and S. Yagel Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9 Mol. Hum. Reprod., April 1, 2004; 10(4): 229 - 235. [Abstract] [Full Text] [PDF]

				K. Hirtenlehner, J. Pollheimer, C. Lichtenberger, M. F. Wolschek, H. Zeisler, P. Husslein, and M. Knofler Elevated Serum Concentrations of the Angiogenesis Inhibitor Endostatin in Preeclamptic Women Reproductive Sciences, October 1, 2003; 10(7): 412 - 417. [Abstract] [PDF]

				D. Islami, P. Bischof, and D. Chardonnens Modulation of placental vascular endothelial growth factor by leptin and hCG Mol. Hum. Reprod., July 1, 2003; 9(7): 395 - 398. [Abstract] [Full Text] [PDF]

				I. P. Crocker, B. K. Strachan, G. E. Lash, S. Cooper, A. Y. Warren, and P. N. Baker Vascular Endothelial Growth Factor But Not Placental Growth Factor Promotes Trophoblast Syncytialization In Vitro Reproductive Sciences, December 1, 2001; 8(6): 341 - 346. [Abstract] [PDF]

				E. R. Norwitz, D. J. Schust, and S. J. Fisher Implantation and the Survival of Early Pregnancy N. Engl. J. Med., November 8, 2001; 345(19): 1400 - 1408. [Full Text] [PDF]

				G. Bocci, A. Fasciani, R. Danesi, P. Viacava, A. R. Genazzani, and M. D. Tacca In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels Mol. Hum. Reprod., August 1, 2001; 7(8): 771 - 777. [Abstract] [Full Text] [PDF]

				J. Y. M. Tse, T. T. Lao, C. C. W. Chan, P. M. Chiu, and A. N. Y. Cheung Expression of Vascular Endothelial Growth Factor in Third-Trimester Placentas Is Not Increased in Growth-Restricted Fetuses Reproductive Sciences, April 1, 2001; 8(2): 77 - 82. [Abstract] [PDF]

				N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato Expression of Vascular Endothelial Growth Factor and Its Receptors in the Human Corpus Luteum during the Menstrual Cycle and in Early Pregnancy J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3919 - 3924. [Abstract] [Full Text]

				S. Khan, H. Katabuchi, M. Araki, R. Nishimura, and H. Okamura Human Villous Macrophage-Conditioned Media Enhance Human Trophoblast Growth and Differentiation In Vitro Biol Reprod, April 1, 2000; 62(4): 1075 - 1083. [Abstract] [Full Text]

				B.-Q. Shen, D. Y. Lee, and T. F. Zioncheck Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway J. Biol. Chem., November 12, 1999; 274(46): 33057 - 33063. [Abstract] [Full Text] [PDF]

				S. M. Hyder and G. M. Stancel Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins Mol. Endocrinol., June 1, 1999; 13(6): 806 - 811. [Full Text]